Close
Smartlab Europe
Achema middle east

content

Stem Cell and Regenerative Therapies for Hearing Loss

The year 2018 marks a notable milestone in the history of stem cell and regenerative medicine. It was twenty years ago, in 1998, that...

A collaborative approach to innovation in Pharma

“IGNITE is a creative environment that fosters innovative thinking and encourages new ideas and enables users to have their voice heard in overcoming challenges...

Tracelink Global Drug Supply Report 2017

  TraceLink’s Global Drug Supply, Safety and Traceability Report survey highlights a lack of industry readiness for U.S. DSCSA, and concerns in...

The use of gamma sterilized, pre-filled syringe plungers for Ready-to-Use primary packaging components

Historically, injectable drugs havemostly been packaged aseptically, with pharmaceutical laboratoriescarrying out the sterilization of the primary packaging components internally. The conventional solution is for pharmaceutical...

Final results from landmark DYNAGITO® trial published in The Lancet Respiratory Medicine

Boehringer Ingelheim announced data from the landmark 52-week DYNAGITO® trial which show that in people with COPD (chronic obstructive pulmonary disease), Spiolto®Respimat® (tiotropium/olodaterol 5/5µg)...

Lokelma approved in the EU for the treatment of adults with hyperkalaemia

AstraZeneca announced that the EC has granted marketing authorisation for Lokelma (formerly ZS-9, sodium zirconium cyclosilicate) for the treatment of adults with hyperkalaemia. ...

Takeda Statement Regarding Shire plc

Takeda Pharmaceutical Company Limited notes the share price movement with respect to Shire plc. Takeda confirms that it is considering making...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »